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Two dipeptide drugs are synthesized utilizing an acetylsalicylic
acid or nicotinic acid molecule for the framework. A D-alanineD-alanine dipeptide moiety is attached to the carbonyl carbon of
acetylsalicylic acid (I) and nicotinic acid (II). Dipeptide derivatives
(I) and (II) showed signiﬁcant reduction of Escherichia coli (E. coli)
bacterial growth and colony-forming units. A mixture of (I) and
(II) induced growth inhibition of 8%, 17.5%, 28%, and 42.5% at
concentrations of 100, 200, 300, and 400 μg/mL, respectively. Ampicillin demonstrated much less growth inhibition of this penicillinresistant E. coli bacteria. Derivatives (I) and (II) showed significant reduction of colony-forming units at concentrations higher
than 200 μg/mL, whereas ampicillin showed no signiﬁcant affect
on colony-forming units. Both (I) and (II) produced no violations of
the Rule of 5, indicating favorable characteristics for bioavailability. Molecular properties were determined and showed (I) to have a
Log Kow of −0.22 with aqueous solubility of 683.8 mg/L, whereas
(II) had a Log Kow of −1.00 and aqueous solubility of 6859 mg/L. A
mixture of the parent compounds acetyl salicylic acid and nicotinic
acid demonstrated some antibacterial activity.
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INTRODUCTION
Escherichia coli is an enteric bacteria (family Enterobacteriaceae) that is a facultatively anaerobic Gram-negative rod. The
Enterobacteriaceae are among the most important bacteria medically and E. coli has been linked to diseases found in many
parts of the body. E. coli is the most encountered bacteria in the
clinical laboratory and is the number one cause of urinary tract
infections, but it is also responsible for pneumonia, meningitis,
and diarrhea (Davis et al. 1990).

Received 10 January 2006; accepted 28 February 2006.
Address correspondence to Ronald Bartzatt, Durham Science Center, Medicinal Chemistry Laboratory, 6001 Dodge St., Omaha, NE
68182, USA. E-mail: bartzatt@mail.unomaha.edu

Antibiotic resistance expressed by bacterial pathogens is a
global problem.The various mechanisms of antibiotic resistance
include alteration/modiﬁcation of the target site, degradation of
antibiotic molecule, and reduced intracellular concentration due
to decreased permeability and energy-dependent efﬂux (Kumar,
Herbert, and Schweizer 2005). The synergism between reduced
uptake and drug efﬂux results in intrinsic or acquired resistance
in many clinically important Gram-negative bacteria (Kumar
et al. 2005).
Clinical isolates of diarrheogenic E. coli have high levels of
multidrug resistance in previous studies (Estrada-Garcia et al.
2005). E. coli can induce persistent diarrhea that has been associated with malnutrition, growth impairment, and death in
developing countries (Nataro and Kaper 1998). Gram-negative
bacteria (inclusive of E. coli) have shown high levels of resistance to beta-lactam antibiotics and in particular to ampicillin
(Al Sweih, Jamal, and Rotimi 2005). E. coli isolates obtained
from fecal polluted waters showed multidrug resistance to even
high concentrations of 14 antibiotics, that included ampicillin
(Edge and Hill 2005). Isolates of E. coli showed high frequency
of resistance to ampicillin from Tanzania (Blomberg et al. 2005),
Vietnam (Nguyen et al. 2005), northern Palestine (Adwan et al.
2004), Korea (Hong, Chun, and Lee 2004), and Taiwan (Lau,
Peng and Chang 2004). Hospital sewage has been found associated with the high incidence of E. coli resistance to antibiotics
ampicillin, piperacillin, cefalothin, nalidixic acid, and tetracycline (Reinthaler et al. 2003).
Nonsteroidal anti-inﬂammatory drugs (NSAIDs) have been
applied in cotreatment of bacterial infections and they have
been shown to play a role in the effective struggle against infections (Katler and Weissmann 1977). Many NSAIDs, inclusive of acetylsalicylic acid, have shown signiﬁcant inhibition
of bacterial clinical isolates (Fouda 2001). Acetylsalicylic acid
has been utilized beneﬁcially with vancomycin to treat E. faecalis and methicillin-resistant S. aureus endocarditis (Marangos
et al. 1997). A previous study has shown that acetylsalicylic acid
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with ibuprofen and interferon-gamma can signiﬁcantly reduce
bacteria presence in the spleen, liver, and main organs of a patient having infection of Listeria monocytogenes (Hockertz and
Heckenberger 1996). In addition, the combination of acetylsalicylate with lidocaine hydrochloride was shown to have antibacterial activity with Gram-negative and Gram-positive bacteria
(Obsuka et al. 1994).
Our work shows the efﬁcacy of utilizing acetylsalicylic acid
and nicotinic acid to transport a dipeptide moiety and initiate
signiﬁcant antibacterial affects. Each of the parent compounds
convey molecular properties that differentiate the two drugs and
imparts useful pharmaceutical activity. In addition, previous
studies have shown clearly that concomitant use of acetylsalicylic acid in the clinical treatment of bacterial infections is
beneﬁcial (Fouda 2001).

MATERIALS AND METHODS
Reagents and Instrumentation
All reagents were obtained from Aldrich Chemical Co.
(Milwaukee WI USA). Infrared spectra were determined by
a Mattson Galaxy 3000 Fourier transform-IR spectrometer in
dimethylsulfoxide dried over molecular sieves. Molecular modeling and properties were determined by ChemSketch (Toronto,
Ontario, Canada), CS Chem3D Pro (CambridgeSoft Corp.,
Cambridge MA, USA), SPARTAN (Wavefunction, Irvine, CA,
USA) and Molinspiration (Slovensky Grob, Slovak Republic).
Tissue culture experiments were accomplished at the Dept. of
Veterinary & Biomedical Sciences, University of Nebraska,
Lincoln, Nebraska, USA.

Synthesis of Dipeptide Drugs
We placed into separate reaction vessels 0.607 g
(0.03367 mol) of acetyl-salicylic acid and 0.415 g (0.03367 mol)
of nicotinic acid. Then, we placed 20 mL to 30 mL of acetonitrile (dried of molecular sieves) into each vessel and 1 mL of
pyridine (proton sink). Next 1 mL of thionyl chloride was added
to each vessel and reﬂuxed for at least 1 hr under mild heat. We
distilled out excess thionyl chloride, adding additional acetonitrile as needed. Then, 0.30 g of D-alanine was added to both
mixtures and reﬂuxed mildly for 60 to 90 min. We cooled the
mixtures and added 1 to 2 mL of pyridine to each reaction solution. Then, we added to each vessel 1 mL of thionyl chloride,
reﬂuxed for at least 1 hr under mild heat. Again we distilled
out excess thionyl chloride and added acetonitrile to maintain
volume. Last we added an additional 1 mL of pyridine, then
0.30 g D-alanine and reﬂuxed mildly for 60 to 90 min. The ﬁnal
volume was reduced by distillation, then precipitated out the ﬁnal product by overnight incubation at −10◦ C and ﬁltration at
4◦ C. Finally we washed the product with diethyl ether chilled to
−10◦ C and stored desicated at −10◦ C.

Culture Method
The following mixtures of parent compounds, dipeptide
drugs, and ampicillin were tested in culture with penicillinresistant E. coli: Nicotinic acid and acetylsalicylic acid at a mole
ratio of 1:1; derivatives (I) and (II) at a mole ratio of 1:1; and
ampicillin. The mixtures above were ﬁrst solubilized in liquid
Luria-Bertani (LB) media and dispensed in known concentrations, followed by inoculation with penicillin-resistant E. coli.
Number of colony-forming units were assayed and optical densities of cultures were measured at 600 nm after 5 hr at 37◦ C to
evaluate antibacterial activity.
RESULTS AND DISCUSSION
Many important pathogens are found to be resistant to multiple antimicrobial classes, resulting in expensive treatment that is
prone to failure (Deshpande, Fritsche, and Jones 2004). Efforts
to respond to this growing threat has yielded new agents. In addition, the formation of novel derivatives of existing antimicrobials has been shown to have merit (Poole, Russell, and Lambert
2005). Ampicillin is a member of the penicillin family of antibiotics (classiﬁed as an aminopenicillin) that are able to penetrate
Gram-negative bacteria and are considered inhibitors of cell wall
synthesis. The structure of ampicillin is based upon the betalactam ring and these types are primarily bactericidal (Davis
et al. 1990). Ampicillin interferes with cell wall formation by
inhibition of the transpeptidation reaction due to the close structural analogy between D-alanine-D-alanine to the beta-lactam
ring.
If the normal transpeptidation reaction within the bacterial
cell wall occurs then new cross-linking occurs involving the
initial -L-lysine-D-alanine-D-alanine side chain to form a new
-L-lysine-D-alanine-glycine linkage. The aim of forming the
D-alanine-D-alanine dipeptide derivatives shown in this work
is to provide an alternative target in place of the -L-lysine-Dalanine-D-alanine side chain. If successful the bacterial cell wall
cannot close normally and in consequence will form perturbations in the cell wall that may be lethal. This will manifest itself
in terms of growth inhibition of the bacteria (E. coli in this work).
Acetylsalicylic acid and nicotinic acid are medications utilized as a NSAID or cholesterol management, respectively. Both
parent compounds have an aromatic ring and carbonyl carbon
suitable for activation and formation of an amide or ester group.
The structural substituents of the parent compounds inﬂuence
the molecular properties of their dipeptide derivatives and consequently their “druglikeness”. Although the parent compounds
have structual features in common, the formation of dipeptide
derivatives having a D-alanine-D-alanine substituent showed
signiﬁcant dissimilarites. The molecular structures of (I) and
(II) are presented in Figure 1 with SMILES notation. The amino
acid D-alanine has polar surface area of 63.32 Angstroms2 with
signiﬁcant hydrophilic nature illustrated by a 1-octanol/water
partition coefﬁcient of −2.692. The formation of a dipeptide D-alanine-D-alanine combination signiﬁcantly alters the
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TABLE 2
Properties of dipeptide derivatives
Property
Molar volume
Parachor
Molar refractivity
Dipole
1
Log BB

Derivative I

Derivative II

251.2 cm3
670.4 cm3
79.48 cm3
10.295 Debye
−0.457

206.8 cm3
563.0 cm3
66.23 cm3
5.083 Debye
−0.667
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BB = DrugBrain /DrugBlood .

FIG. 1. Molecular structures of dipeptide derivatives (I) and (II) are shown
with SMILES notation. The D-alanine-D-alanine substituents are attached to
the carbonyl carbon present in the parent compounds. Both (I) and (II) have
aromatic rings within their structures.

partition coefﬁcient that becomes −3.26 (more hydrophilic) and
increases the polar surface area to 92.42 angstroms2 (a 46% increase). Thus, a dipeptide moiety may signiﬁcantly affect druglikeness properties of a derivatized agent.
The affects on molecular properties and inﬂuence on parent
compound structure after addition of D-alanine-D-alanine substituent can be readily seen in Table 1. Comparison of molecular

properties of (I) and (II) to the parent structures acetylsalicylic
acid and nicotinic acid, respectively, shows some striking alterations. The polar surface area of (I) and (II) are approximately
double that of their respective parent compound. Derivatives
(I) and (II) have substantially less water solubility than their
repective parent compounds that decrease by more than 85%
for acetylsalicylic acid and nicotinic acid. This is reﬂected by a
more hydrophilic Log Kow for (I) and (II) (i.e., negative values
for Log Kow). The Log Kow values for acetylsalicylic acid and
nicotinic acid are more lipophilic at values of 1.13 and 0.69,
respectively. Both (I) and (II), the parent drugs, in addition to
ampicillin show zero violations of the Rule of 5. This indicates
favorable propperties for drug absorption and less probability of
problems in permeation (Lipinski et al. 1997).
Additional properties (descriptors) of molecular size, dipole,
and penetration of the blood-brain barrier (BBB) membrane
are presented in Table 2. The aromatic ring, and in the case of
acetylsalicylic acid the acetyl group ( C(O)CH3 ), contributes
to the dissimilarity of (I) from (II). The molecular dipole of I is
10.295 Debye compared with 5.083 Debye of (II). In general, a
large dipole value does not enhance membrane permeation. The
pyridine-like ring of (II) clearly affects the overall molecular
dipole and reduces the value compared with the inﬂuence of the
acetylsalicylic acid moiety. The acetyl group contained within
(I) as expected would contribute to a larger value of molecular
size, indicated by greater values for molar volume, parachor,
and molar refractivity. Molar refractivity is a measure of both
molecular volume and efﬁcacy of polarization.
Numerical values for Log BB (log (Cbrain/Cblood)) are determined by correlation with partition coefﬁcient and molecular

TABLE 1
Molecular properties of compounds
Property

Ampicillin

Acetylsalicylic acid

Nicotinic acid

Derivative I

Derivative II

Formula weight
Polar surface/area
Log Kow
Water solubility
Violations of Rule of 5

349.4
112.7 A2
−1.546
6133 mg/L
0

180.2
63.60 A2
1.13
5295 mg/L
0

123.1
50.19 A2
0.69
48150 mg/L
0

322.3
121.8 A2
−0.22
683.8 mg/L
0

265.3
108.4 A2
−1
6859 mg/L
0

A = angstroms, mg = milligrams.
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PERCENT GROWTH INHIBITION versus DRUG CONCENTRATION

FIG. 2. There is substantial inhibition of bacterial growth as indicated by
the plot of Percent Inhibition versus Concentration in μg/mL. The mixture of
nicotinic acid and acetylsalicylic acid expresses greater than 15% inhibition at
concentrations above 200 μg/mL. The mixture of dipeptides (I) and (II) express
greater than 15% inhibition at even lower concentrations of 160 μg/mL. Growth
inhibition induced by (I) and (II) increases at a faster rate than other compounds
to reach greater than 50% inhibition at 500 μg/mL. In the concentration ranges
shown to be effective for (I) and (II), the growth inhibtion induced by ampicillin
remains below 10%.

mass as a descriptor of bulkiness (Kaznessis et al. 2001): Log
BB = −0.088 + 0.272(Log P) − 0.001116(molecular weight).
The results of Log BB determination give BB values of 0.349 and
0.215 for (I) and (II), respectively. These values indicate only
a small fraction of drug present at the BBB interface would be
expected to successfully cross into the central nervous system.
Signiﬁcant growth inhibition of penicillin-resistant E. coli
was induced by a mixture of (I) and (II) (mole ratio of 1:1)
and by the parent compounds at concentrations of greater than
300 μg/mL. Results of in vitro growth inhibition evaluation are
shown in Figure 2. A mixture of (I) and (II) induced growth
inhibition of 8%, 17.5%, 28%, and 42.5% at concentrations
of 100 μg/mL, 200 μg/mL, 300 μg/mL, and 400 μg/mL, respectively. Linear regression analysis of the trend line results
in the linear equation: y = 0.1050 × −1.800 (r = 0.9934 and
R2 = 0.9868). Ampicillin showed considerably less growth inhibition (less than 10%) of this penicillin-resistant E. coli bacteria
at all concentrations. Ampicillin showed less than 5% growth
inhibition at all concentrations less than 300 μg/mL. Clearly a
more beneﬁcial results are obtained with a mixture of (I) and
(II). In addition, a mixture of acetylsalicylic acid and nicotinic
acid (mole ratio 1:1) induced growth inhibition of greater than
15% when at concentrations greater than 250 μg/mL.
Reduction of colony-forming units (CFUs) also is indicative of growth inhibition. A pair, chain, or cluster of bacterial
cells in close proximity to each other can multiply to produce
a single colony. The term CFU is applied to consider the common origin for the cells of any colony. Whether colony counts
are performed or not, bacterial colonies still arise from CFUs.

Inhibition of Growth Rate by Colony Forming Units (CFU)

FIG. 3. Inhibition of colony-forming units also is indicative of bacterial
growth inhibition. For ampicillin the number of CFUs continually increases
throughout the studied region. However, for (I) and (II) the number of CFUs
immediately decreases and continues to decrease throughout the concentration
range. The parent nicotinic acid and acetylsalicylic acid also induce signiﬁcant
reduction of CFUs throughout the range of concentrations.

Assessment of CFUs is presented in Figure 3 versus concentration in micrograms per milliliter. Throughout all concentrations of ampicillin, the number of CFUs increases, indicating
no growth inhibition. However in both cases of mixtures of (I)
with (II) and acetylsalicylic acid with nicotinic acid a substantial
reduction of the number of CFUs occurs. Assay for (I) and (II)
mixture shows large reduction of CFUs at concentrations greater
than 240 μg/mL.
CONCLUSION
Two -D-alanine-D-alanine dipeptide derivatives were formed
using acetylsalicylic acid and nicotinic acid as the parent compounds. The two derivatives were sufﬁciently stable and soluble
in aqueous solution and physiological 37◦ C to inhibit the growth
and formation of CFUs of a penicillin-resistant E. coli bacteria.
Both derivatives showed zero violations of the Rule of 5. A
mixture of both derivatives induced growth inhibition at levels
of 8%, 17.5%, 28%, and 42.5% at concentrations of 100 μg/mL,
200 μg/mL, 300 μg/mL, and 400 μg/mL, respectively, whereas
the antibiotic ampicillin showed less than 10% growth inhibition
at concentrations up to 400 μg/mL. The dipeptide derivatives
also demonstrated signiﬁcant reduction of CFUs as opposed to
ampicillin that actually showed increased number of CFUs.
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